Longevity Scientist: Aging Is A Disease. We Just Don’t Know How to Treat (yet)

Joe Betts-LaCroix and Retro Biosciences recently raised funding at a $1.8 billion valuation. In his first podcast appearance since the announcement, Joe shares his vision for extending healthy human lifespan and the breakthroughs driving the longevity industry forward.

Joe Betts-LaCroix explains why aging is becoming a legitimate scientific target. He shares how new discoveries are turning longevity from speculation into measurable biology.

The conversation explores how AI is accelerating research, while highlighting why biology remains one of the hardest problems to solve. Even with smarter models, real-world testing and clinical trials still take time.

Joe also discusses Alzheimer's, partial cellular reprogramming, and the future of longevity medicine. He shares why exercise remains the best longevity tool available today and what the next decade could look like for human health.

Joe is the CEO of Retro Biosciences and a longtime entrepreneur focused on science and technology. His mission is to extend healthy human lifespan and accelerate breakthroughs in aging research.

This episode is brought to you by NADclinic, the go-to destination for longevity and human performance. Check them out at https://nadclinic.com.

What You’ll Learn

• Why Sam Altman backed Retro Biosciences

• The discovery that changed aging research forever

• How AI is transforming biotech and longevity

• Why curing all diseases in 10 years is unlikely

• What Retro's Alzheimer's programs are targeting

• Why biology is harder than most people realize

• The longevity intervention Joe recommends today

• How aging may become a treatable condition

• What the longevity industry could look like by 2030

• Joe's vision for the future of human health and AI

  
  

⏱ Timestamps

00:00 Intro

00:16 AI's Role in Longevity

03:26 Will AI Cure All Diseases?

09:41 Why Biology Is So Hard to Solve

13:17 Building Technology That Matters

15:06 Adding 10 Healthy Years to Life

18:08 Inside Retro's Clinical Trial

19:31 The Different Types of Longevity Companies

22:10 Are We Already in the Singularity?

24:46 Why Investors Are Betting on AI Biotech

26:15 AI as the New Electricity

27:01 The Biggest Risks Facing Longevity

30:54 Why More Competition Is Good

32:44 Solving Alzheimer's Disease

34:26 Aging Biology and Future Therapeutics

38:25 The Biggest Aging Myth

39:41 The Most Underrated Voices in Longevity

40:25 The Best Longevity "Hack"

46:13 The Future of Longevity by 2030

50:49 If Tomorrow Was Your Last Day...

Follow Joe:

Website: https://www.retro.bio/

LinkedIn: https://www.linkedin.com/in/bettslacroix

X: https://x.com/bettslacroix

Connect with Julian

Instagram: https://www.instagram.com/thebeyondtomorrowpodcast/

Instagram: https://www.instagram.com/juliankissa/

LinkedIn: https://uk.linkedin.com/in/julian-issa

Website: www.beyondtomorrowpodcast.com

Email: bookings@beyondtomorrowpodcast.com

Subscribe on Spotify, Apple, and YouTube for more stories from the edge of what is possible.